Pharma News, 2022

The vaccine delivery system uses DNA to encode genetic instruction in vivo, producing a more efficacious immune response.

Covid was the common currency as three top pharma groups reported results. 

Review of development program led to reassessment of benefit-risk ratio in all four potential indications for the investigational P2X3 receptor antagonist.

Eli Lilly said it will hold off on seeking accelerated approval of its investigational Alzheimer’s drug, donanemab, until later this year, rather than completing filing during the first quarter a...

Today, privately held Navitor Pharmaceuticals, LLC, announced that Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson has acquired Anakuria Therapeu...

Britain's GlaxoSmithKline will receive $1.25 billion from Gilead Sciences as part of a settlement between its HIV medicines unit and the U.S.-based drugmaker, ending a long-drawn patent d...

The U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on a series of trials investigating the use using umbralisib in combination with ublituximab (U2) as a treatment for c...

Timber Pharmaceuticals announced the successful completion of an End-of-Phase 2 meeting with the U.S. FDA resulting in a clear path towards a pivotal Phase 3 study for its lead asset, TMB-001, a to...

PFAS, a family of thousands of human-made chemicals, are everywhere, and some of them are known to be harmful for our bodies and the environment.

The FDA approved the first generic of cyclosporine ophthalmic emulsion (Restasis) for dry eye, a condition that affects millions of Americans each year.

Like most vaccines, RNA vaccines have to be injected, which can be an obstacle for people who fear needles.

Glenmark Pharmaceuticals USA has received FDA’s approval for its generic version of MetroGel-Vaginal Gel (metronidazole) 0.75 percent made by Bausch Health.